FITZGERALD MEGHAN sold 62.0% of their position (70K shares) of ROIVANT SCIENCES LTD. on the open market
Open‑market sale worth $1.92M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/30/2026ACC: 0001140361-26-012063
-70K
Net shares
Net seller
$1.92M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
70K acquired · 140K disposed
Non-Derivative Transactions2
Common Shares
Direct
Shares
+70K
Price / share
$8.80
Trade value
$616K
% of position
162.9%
3/26/2026
42.96K→112.96K
Common Shares
Direct
Shares
−70K
Price / share
$27.45
Trade value
$1.92M
% of position
62.0%
3/26/2026
112.96K→42.96K
Total
Net shares
+0.00
Net value
-$1.31M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 3/26/2026 | M · Option Exercise | +70K | $8.80 | $616K | 162.9% | 42.96K | 112.96K |
| Common Shares Direct | 3/26/2026 | S · Sale | −70K | $27.45 | $1.92M | 62.0% | 112.96K | 42.96K |
| Total | +0.00 | -$1.31M | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
70K shares
Shares
−70K
Strike price
8.8
Held after
48.58K
Exercisable
—
3/26/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock70K shares | 3/26/2026 | M · Option Exercise | −70K | 8.8 | — | 48.58K |